From April 1, 2022 to June 30, 2022, the company has repurchased 79,620 shares, representing 0.03% for CNY 4.86 million. With this, the company has completed the repurchase of 759,620 shares, representing 0.24% for CNY 54.71 million under the buyback announced on February 7, 2022.
Qingdao Haier Biomedical Co.,Ltd
Equities
688139
CNE100003P25
Advanced Medical Equipment & Technology
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
37.26 CNY | +0.84% | +0.89% | -8.05% |
EPS Revisions
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-8.05% | 1.63B | |
+7.84% | 218B | |
+7.35% | 184B | |
+13.04% | 135B | |
+26.03% | 107B | |
-1.33% | 62.38B | |
+11.80% | 51.37B | |
+4.81% | 50.9B | |
+0.30% | 40.87B | |
+2.78% | 36.28B |
- Stock Market
- Equities
- 688139 Stock
- News Qingdao Haier Biomedical Co.,Ltd
- Tranche Update on Qingdao Haier Biomedical Co., Ltd's Equity Buyback Plan announced on February 7, 2022.